The relationship of recurrent spontaneous miscarriage with reproductive failure

Medical Principles and Practice

Volumn 12, Issue 2, 2003, Pages 107-111

  Diejomaoh, Michael ^a   Jirous, Jiri ^b   Al Azemi, Magda ^a   Baig, Saba ^b   Gupta, Madhu ^b   Tallat, Alaa ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

Polycystic ovaries; Recurrent miscarriage; Reproductive failure

Indexed keywords

ABORTION; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BODY MASS; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HISTORY OF MEDICINE; HUMAN; MEDICAL ASSESSMENT; OVARY POLYCYSTIC DISEASE; PHYSICAL EXAMINATION; PREGNANCY; PROSPECTIVE STUDY; REPRODUCTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; HUMANS; INFERTILITY, FEMALE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 0347926333     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069122     Document Type: Article

References (29)

1. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R: Effects of metformin on spontaneous and clomiphene-induced ovulation in polycystic ovary syndrome. N Engl J Med 1998;338: 1876-1880.
2. Omu AE, Ismail AA, Al-Qattan F: Infertility in Kuwait. Int J Gynecol Obstet 1999;67:113-114.
3. Franks S: Polycystic ovary syndrome. N Engl J Med 1995;333:835-861.
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1165-1174.
5. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polansky KS: Insulin secretory defects in polycystic ovary syndrome: Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995;96:520-527.
6. Apter D, Butzow T, Langhlin GA, Yen SS: Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995; 80:2966-2973.
7. Clifford K, Rai R, Watson H, Reagan L: An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases. Hum Reprod 1994;9: 1328-1332.
8. Royal College of Obstetricians and Gynaecologists (RCOG): The Management of Recurrent Miscarriage. Guidelines No. 17. London, RCOG, 1998, pp 1-10.
9. Diejomaoh MFE, Al-Azemi M, Jirous J, Bandar A, Egbase P, Al-Sweih N, Al-Othman S: The aetiology and pattern of recurrent pregnancy loss. J Obstet Gynaecol 2002;22:62-67.
10. Sills ES, Levy DP, Wittkowski K, Perloe M: Preliminary experience with metformin treatment of polycystic ovary syndrome: Reproductive outcomes among 20 consecutive patients. Fertil Steril 1999;72:S187-S188.
11. Diejomaoh MF, Al-Azemi MM, Bandar A, Eg-base PE, Jirous J, Al-Othman S, Bukhadour N, Al-Sweih N: A favourable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome. Arch Gynecol Obstet 2002;266:61-66.
12. Kutteh WH, Pasquarette MM: Recurrent pregnancy loss; in Advances in Obstetrics and Gynaecology. St Louis, Mosby Year Book, 1995, vol 2, pp 147-177.
13. Craig LB, Ke RW, Kutteh WH: Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002;78:487-490.
14. Unluhizarci K, Kelestimur F, Bayram F, Sahin Y, Tutus A: The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:231-236.
15. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P: Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study. Fertil Steril 2001;75:46-52.
16. Kocak M, Caliskan E, Simsir C, Haberal A: Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomi-phene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101-106.
17. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE: Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001;75: 310-315.
18. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41:1257-1266.
19. Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L: Metformin therapy decreases hyperandrogenism and hyperinsulinaemia in women with polycystic ovary syndrome. Fertil Steril 2000;73:1149-1154.
20. Velazquez E, Mendoza SG, Wang O, Glueck CJ: Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein (a), and immunoreactive insulin levels in patients with polycystic ovary syndrome. Metabolism 1997;46:454-457.
21. Glueck CJ, Wang P, Sieve-Smith L, Fontaine R, Tracy T, Moore SK: Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999;48:1589-1595.
22. Glueck CJ, Wang P, Sieve-Smith L, Fontaine R, Tracy T: Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome. Metabolism 1999;48:511-519.
23. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS: Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) in lean women with and without the polycystic ovary syndrome. Clin Endocrinol 1996;45:623-629.
24. Atiomo WU, Fox R, Condon JE, Shaw S, Friend J, Prentice AG, Wilkin TJ: Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Clin Endocrinol 2000;52: 487-492.
25. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P: Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) study. Thromb Haemost 1997; 77:1096-1103.
26. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF: Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993;122:606-615.
27. Velazquez E, Acosta A, Mendoza SG: Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997; 90:392-395.
28. Warburton D, Fraser FC: Spontaneous abortion risks in man: Data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964;16:1-25.
29. Stirrat GM: Recurrent miscarriage: Definitions and epidemiology. Lancet 1990;336:673-675.